These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 10338071

  • 1. Use of recombinant human erythropoietin (EPO-alfa) in a mother alloimmunized to the Js(b) antigen.
    Santolaya-Forgas J, Vengalil S, Duval J, Gottmann D, Meyer W, Gauthier D, DeChristopher PJ.
    J Matern Fetal Med; 1999; 8(3):141-5. PubMed ID: 10338071
    [Abstract] [Full Text] [Related]

  • 2. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E, Nikoloudi I, Kaminopetros P, Bolonaki I, Sifakis S, Kikidi K, Koumantakis E, Foundouli K.
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [Abstract] [Full Text] [Related]

  • 3. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ, Al Salmani M, Al Hashami S, Al Mahrooqi S, Al Hinai S, Al Balushi H, Al Riyami N, Gowri V, Al Dughaishi T, Al Hosni S, Al-Khabori M, Al-Farsi K, Al Huneini M, Alkindi S.
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [Abstract] [Full Text] [Related]

  • 4. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD, Gordon MC, Higby K.
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S, al Omran A.
    J Perinat Med; 1999 Nov; 27(2):112-5. PubMed ID: 10379500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
    Manoura A, Korakaki E, Hatzidaki E, Saitakis E, Maraka S, Papamastoraki I, Matalliotakis E, Foundouli K, Giannakopoulou C.
    Pediatr Hematol Oncol; 2007 Nov; 24(1):69-73. PubMed ID: 17130116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
    Tantalo V, Rossi E, Gianotti GA, Morotti R, Zuliani G, Buscaglia M, Galligani M.
    Ann Ostet Ginecol Med Perinat; 1990 Nov; 111(5):321-5. PubMed ID: 2092607
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I, Schlenke P, Härtel C.
    Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F, Samanci N, Dağoğlu T.
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.